Russell Banner

Treating people with cancer's the day job.

Clinical Director @SWWCancerCentre

[Russell Banner @drrsl]

Already recruiting Dani, Welsh @swwcc patients are in. Open @VelindreCS

[Dani Akrigg @DaniAkrigg]

England NHS to fast track head and neck cancer patients on to mRNA vaccine trial. And Wales? @SWWCancerCentre

https://t.co/aG1NRIuNdn

[Claire Paterson 💙 @claire_paters0n]

A day of celebration for 2 of our Glasgow H&N cancer (GlaHNC) research group members yesterday @UofGlasgow @UofGMVLS. 26 years after my 1st graduation it was great to be back to be awarded MD. Many congratulations to @CraigDSmith99 on his PhD 👏🏻 #hncsm

[Ravi Uppaluri, MDPhD @DrUppaluri]

Here it is! KEYNOTE-689 primary publication online now @NEJM. It’s been an incredible journey with DAdkins @SitemanCenter @WUSM. All started in early 2010s / now with @US_FDA approval and a new standard of care! @DanaFarberNews @BrighamWomens @BrighamSurgery

[R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) @rbryanbell]

Boom!💥 ⁦@FDA⁩ approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. https://t.co/RXSqwO03t5

[Russell Banner @drrsl]

@DaniAkrigg @SWWCancerCentre Short answer is no we're not.

https://t.co/2u1JYBZ3db

[Dani Akrigg @DaniAkrigg]

I had six weeks radiotherapy at the Singleton. My husband used to look forward to cake day. Me? I couldn’t eat so he had two helpings to make up for it. Lovely ladies. Well done. @SWWCancerCentre

[Russell Banner @drrsl]

This is a great group of engaged and motivated clinicians to be part of, all seeking to improve patient care as we deliver it in Wales. Thank you @BevanCommission for giving us the opportunity to learn from and quiz those who have gone before and given us tools to go further 👍

[Bevan Commission @BevanCommission]

Today, our Clinical Influencers (Cohort 3) have joined us in Cardiff (@PublicHealthW) for their final workshop.

[Russell Banner @drrsl]

The problem is UK wide, and it's exacerbated regionally

So a combined regional and national approach is essential for sustainability and equity of service to be achieved

[Russell Banner @drrsl]

Recruit Retain Train

[The Royal College of Radiologists @RCRadiologists]

Patients are facing dangerous delays to life-saving scans and treatment due to the chronic shortage of doctors in the NHS.

The government must train and recruit more radiologists and oncologists to meet future demand.

Read our 2024 census reports: https://t.co/Ua1Il2HCpA

[David Sher @DavidSherMD]

This study reports on incredible results with adjuvant cemiplimab in high-risk cutaneous squamous cell carcinoma.

https://t.co/rRgKdwcr0g

[Melvin LK CHUA | FRCR, PhD, FASCO @DrMLChua]

Very powerful and insightful discussion by Prof Kevin Harrington @royalmarsden on KN-630 and C-POST

The slides speak volumes and it isn’t just about the timing of anti-PD-1 😜 @KaramLab @CJTsaiMDPhD @seanmmcbride @PBlanchardMD

#ASCO2025
#Skincancer
#Cutaneouscancer

[Russell Banner @drrsl]

Congratulations to Dr Elin Jones and all the fundraising community around @HywelDdaHB Bronglais Hospital in opening the new Leri Cancer Unit today 👏 👏 👏
https://t.co/hEqKCEE41r

[RTTQA @RTTQA_UK]

Congratulations to our fabulous colleague, mentor and friend @LizMiles_RT on winning the #ESTRO25 Interdisciplinary Award. A true supporter of #collaboration and #RTQA. We could not be prouder nor could it be more well deserved!

[Claire Paterson 💙 @claire_paters0n]

A pleasure to speak to the @simplyoncology team about head & neck cancer in my podcast debut 😬
Hopefully a patient friendly resource
@OracleHNCUK @BAHNOOfficial

https://t.co/UhNCbyGfBe

[Melvin LK CHUA | FRCR, PhD, FASCO @DrMLChua]

1st part of #Radiotherapy Series that deep dives into #PORT for #Headneckcancer

Thanks to @ESTRO_RT and Team led by Profs_Mererid & Vincent with superb colleagues @sueyom @PierluigiBonomo

Part 2 on delineation otw!

Must read for residents!

https://t.co/FdUYMxRlpN

[David Sher @DavidSherMD]

Incredible study on HNSCC ENI now published in @JCO_ASCO

Randomized-controlled trial on ENI dose de-escalation

Nominal dose 50 Gy vs. 43 Gy in 34 fractions

EQD2 44 Gy vs 34 Gy

6 fractions per week, **NO CHEMOTHERAPY**

https://t.co/5yMiGPqfKS

[Russell Banner @drrsl]

Fantastic 2 days back at school @SwanseaUni Value Based Health and Care Instensive Learning Academy - lots to process but embedding what matters to @SWWCancerCentre patients in our joint sustainable @SwanseabayNHS @HywelDdaHB strategy and business cases has to be a good start.

[Eleri Lewis @eleri_lewis]

Raising the profile of South Wales Spinal Network in primary care land today! @SWSpinalNetwork @HywelDdaHB #CES #MSCC #SpinalInfection

[Tîm Cenedlaethol Canser | National Cancer Team @WalesCancerNet]

#NationalCancerCNSDay #DyddCNSCanserCenedlaethol
@SwanseabayNHS @BaeAbertaweGIG @macmillancancer

[Claire Paterson 💙 @claire_paters0n]

@onctrainees
Delighted that our abstract on HNSCCUP has been selected for oral presentation. How does involved neck only radiotherapy compare to bilateral neck & mucosal treatment? Find out in Vienna